Depending on the hypothesis that FABP-4 was closely relevant to glucose metabolism impairment, we aimed to evaluate FABP-4 levels in patients with acromegaly, especially patients with acromegaly-associated DM. The gene discussed is FABP4; the disease is diabetes mellitus.